Search

Your search keyword '"A Wimo"' showing total 76 results

Search Constraints

Start Over You searched for: Author "A Wimo" Remove constraint Author: "A Wimo" Publisher elsevier bv Remove constraint Publisher: elsevier bv
76 results on '"A Wimo"'

Search Results

1. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

2. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

4. MSR136 IPECAD Modeling Workshop 2023 Cross Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease and Related Dementias

5. The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

8. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

11. General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries-A MOPEAD project survey

12. Response and Adherence of Nursing Home Residents to a Nutrition/Exercise Intervention

13. Profiles of Met and Unmet Needs in People with Dementia According to Caregivers’ Perspective: Results from a European Multicenter Study

18. The Use and Costs of Formal Care in Newly Diagnosed Dementia: A Three-Year Prospective Follow-Up Study

19. Relationships between nutritional status, sarcopenia and frailty in nursing-home residents

21. Costs of Care of Agitation Associated With Dementia in 8 European Countries: Results From the RightTimePlaceCare Study

22. CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients

24. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

25. Validity and reliability of assessments of time

28. Time spent on informal and formal care giving for persons with dementia in Sweden

29. Nursing load in different care alternatives in Sweden during 18 years

30. Defeating Alzheimer's disease and other dementias: a priority for European science and society

31. Brain Health: A Primary Health Care Viewpoint

43. P.4.041 Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study

46. Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

47. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

48. Response to donepezil is not predicted by apolipoprotein E genotype and/or gender

Catalog

Books, media, physical & digital resources